Literature DB >> 33172834

Physicians' Perceptions of a Situation Awareness-Oriented Visualization Technology for Viscoelastic Blood Coagulation Management (Visual Clot): Mixed Methods Study.

Tadzio Raoul Roche1, Sadiq Said1, Julian Rössler1, Malgorzata Gozdzik1, Patrick Meybohm2, Kai Zacharowski3, Donat R Spahn1, Christoph B Nöthiger1, David W Tscholl1.   

Abstract

BACKGROUND: Viscoelastic tests enable a time-efficient analysis of coagulation properties. An important limitation of viscoelastic tests is the complicated presentation of their results in the form of abstract graphs with a multitude of numbers. We developed Visual Clot to simplify the interpretation of presented clotting information. This visualization technology applies user-centered design principles to create an animated model of a blood clot during the hemostatic cascade. In a previous simulation study, we found Visual Clot to double diagnostic accuracy, reduce time to decision making and perceived workload, and improve care providers' confidence.
OBJECTIVE: This study aimed to investigate the opinions of physicians on Visual Clot technology. It further aimed to assess its strengths, limitations, and clinical applicability as a support tool for coagulation management.
METHODS: This was a researcher-initiated, international, double-center, mixed qualitative-quantitative study that included the anesthesiologists and intensive care physicians who participated in the previous Visual Clot study. After the participants solved six coagulation scenarios using Visual Clot, we questioned them about the perceived pros and cons of this new tool. Employing qualitative research methods, we identified recurring answer patterns, and derived major topics and subthemes through inductive coding. Based on them, we defined six statements. The study participants later rated their agreement to these statements on five-point Likert scales in an online survey, which represented the quantitative part of this study.
RESULTS: A total of 60 physicians participated in the primary Visual Clot study. Among these, 36 gave an interview and 42 completed the online survey. In total, eight different major topics were derived from the interview field note responses. The three most common topics were "positive design features" (29/36, 81%), "facilitates decision making" (17/36, 47%), and "quantification not made" (17/36, 47%). In the online survey, 93% (39/42) agreed to the statement that Visual Clot is intuitive and easy to learn. Moreover, 90% (38/42) of the participants agreed that they would like the standard result and Visual Clot displayed on the screen side by side. Furthermore, 86% (36/42) indicated that Visual Clot allows them to deal with complex coagulation situations more quickly.
CONCLUSIONS: A group of anesthesia and intensive care physicians from two university hospitals in central Europe considered Visual Clot technology to be intuitive, easy to learn, and useful for decision making in situations of active bleeding. From the responses of these possible future users, Visual Clot appears to constitute an efficient and well-accepted way to streamline the decision-making process in viscoelastic test-based coagulation management. ©Tadzio Raoul Roche, Sadiq Said, Julian Rössler, Malgorzata Gozdzik, Patrick Meybohm, Kai Zacharowski, Donat R Spahn, Christoph B Nöthiger, David W Tscholl. Originally published in JMIR Serious Games (http://games.jmir.org), 04.12.2020.

Entities:  

Keywords:  Visual Clot; avatar; blood coagulation; blood coagulation test; decision making; hemostasis; point of care; qualitative research; rotational thromboelastometry; situation awareness; survey and questionnaires; user-centered design; visualization

Year:  2020        PMID: 33172834     DOI: 10.2196/19036

Source DB:  PubMed          Journal:  JMIR Serious Games            Impact factor:   4.143


  1 in total

1.  Faster Time to Treatment Decision of Viscoelastic Coagulation Test Results through Improved Perception with the Animated Visual Clot: A Multicenter Comparative Eye-Tracking Study.

Authors:  Clara Castellucci; Julia Braun; Sadiq Said; Tadzio Raoul Roche; Christoph B Nöthiger; Donat R Spahn; David W Tscholl; Samira Akbas
Journal:  Diagnostics (Basel)       Date:  2022-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.